{"entity":{"type":"insider","cik":"0001578200","url":"/insider/0001578200","json_url":"/insider/0001578200.json","name":"Schenkein David P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":112,"n_filings":64,"first":"2014-07-02","last":"2024-11-13","span_basis":"filed_date"},"name_variants":[{"name":"Schenkein David P","source":"filing","n_filings":64,"first_seen":"2014-07-02","last_seen":"2024-11-13"}],"transactions":[{"id":2873177,"accession":"0001714899-24-000219","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-24-000219","line_url":"/filing/0001714899-24-000219","is_derivative":false,"issuer_cik":"0001578200","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001578200","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59441.0,"shares_display":"59,441","price_per_share":32.51400632560018,"price_display":"32.51","price_state":"stated","total_value":1932665.05,"total_display":"1,932,665.05","total_whole":"1,932,665","shares_owned_after":9220.0,"shares_owned_after_display":"9,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider","n_lines":2},{"id":2216631,"accession":"0001439222-24-000042","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-24-000042","line_url":"/filing/0001439222-24-000042","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69329.0,"shares_display":"69,329","price_per_share":34.66935899839894,"price_display":"34.67","price_state":"stated","total_value":2403591.99,"total_display":"2,403,591.99","total_whole":"2,403,592","shares_owned_after":122854.0,"shares_owned_after_display":"122,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider","n_lines":2},{"id":2557209,"accession":"0001439222-24-000040","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-24-000040","line_url":"/filing/0001439222-24-000040#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20411.0,"shares_display":"20,411","price_per_share":33.19,"price_display":"33.19","price_state":"stated","total_value":677441.09,"total_display":"677,441.09","total_whole":"677,441","shares_owned_after":122854.0,"shares_owned_after_display":"122,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2557201,"accession":"0001439222-24-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000040","line_url":"/filing/0001439222-24-000040#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47731.0,"shares_display":"47,731","price_per_share":33.05,"price_display":"33.05","price_state":"stated","total_value":1577509.55,"total_display":"1,577,509.55","total_whole":"1,577,510","shares_owned_after":122854.0,"shares_owned_after_display":"122,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-23","filed_date":"2024-02-27","scope":"insider"},{"id":8447256,"accession":"0001439222-23-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000058","line_url":"/filing/0001439222-23-000058#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16363.0,"shares_display":"16,363","price_per_share":22.85,"price_display":"22.85","price_state":"stated","total_value":373894.55,"total_display":"373,894.55","total_whole":"373,895","shares_owned_after":117879.0,"shares_owned_after_display":"117,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8686329,"accession":"0001439222-23-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000056","line_url":"/filing/0001439222-23-000056#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.15,"price_display":"22.15","price_state":"stated","total_value":443000.0,"total_display":"443,000.00","total_whole":"443,000","shares_owned_after":117879.0,"shares_owned_after_display":"117,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":8653191,"accession":"0001439222-23-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-23-000055","line_url":"/filing/0001439222-23-000055","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.4908375,"price_display":"22.49","price_state":"stated","total_value":449816.75,"total_display":"449,816.75","total_whole":"449,817","shares_owned_after":119546.0,"shares_owned_after_display":"119,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-15","scope":"insider","n_lines":2},{"id":8711801,"accession":"0001439222-23-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000041","line_url":"/filing/0001439222-23-000041#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.37,"price_display":"25.37","price_state":"stated","total_value":507400.0,"total_display":"507,400.00","total_whole":"507,400","shares_owned_after":117879.0,"shares_owned_after_display":"117,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":8686317,"accession":"0001439222-23-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000020","line_url":"/filing/0001439222-23-000020#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":28.62,"price_display":"28.62","price_state":"stated","total_value":572400.0,"total_display":"572,400.00","total_whole":"572,400","shares_owned_after":117879.0,"shares_owned_after_display":"117,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":8590395,"accession":"0001439222-23-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-23-000010","line_url":"/filing/0001439222-23-000010","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":29.3289,"price_display":"29.33","price_state":"stated","total_value":586578.0,"total_display":"586,578.00","total_whole":"586,578","shares_owned_after":121179.0,"shares_owned_after_display":"121,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider","n_lines":2},{"id":8733734,"accession":"0001439222-23-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-23-000008","line_url":"/filing/0001439222-23-000008","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":28.854639,"price_display":"28.85","price_state":"stated","total_value":577092.78,"total_display":"577,092.78","total_whole":"577,093","shares_owned_after":118913.0,"shares_owned_after_display":"118,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":2885410,"accession":"0001209191-20-065134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065134","line_url":"/filing/0001209191-20-065134","is_derivative":false,"issuer_cik":"0001578200","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001578200","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":90.05273333333334,"price_display":"90.05","price_state":"stated","total_value":2701582.0,"total_display":"2,701,582.00","total_whole":"2,701,582","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider","n_lines":2},{"id":2084206,"accession":"0001209191-20-058334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058334","line_url":"/filing/0001209191-20-058334#line-1","is_derivative":false,"issuer_cik":"0001578200","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001578200","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":70.053,"price_display":"70.05","price_state":"stated","total_value":2101590.0,"total_display":"2,101,590.00","total_whole":"2,101,590","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2345712,"accession":"0001209191-20-057936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057936","line_url":"/filing/0001209191-20-057936#line-1","is_derivative":false,"issuer_cik":"0001578200","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001578200","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":60.031,"price_display":"60.03","price_state":"stated","total_value":600310.0,"total_display":"600,310.00","total_whole":"600,310","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2690466,"accession":"0001209191-20-057336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057336","line_url":"/filing/0001209191-20-057336#line-1","is_derivative":false,"issuer_cik":"0001578200","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001578200","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.183,"price_display":"50.18","price_state":"stated","total_value":501830.0,"total_display":"501,830.00","total_whole":"501,830","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":8766740,"accession":"0001439222-19-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-19-000023","line_url":"/filing/0001439222-19-000023#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8064.0,"shares_display":"8,064","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":249984.0,"total_display":"249,984.00","total_whole":"249,984","shares_owned_after":97567.0,"shares_owned_after_display":"97,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-15","scope":"insider"},{"id":6101046,"accession":"0001209191-18-035615","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-035615","line_url":"/filing/0001209191-18-035615","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":95.35443846153846,"price_display":"95.35","price_state":"stated","total_value":1239607.7,"total_display":"1,239,607.70","total_whole":"1,239,608","shares_owned_after":3290.0,"shares_owned_after_display":"3,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider","n_lines":4},{"id":6395534,"accession":"0001209191-18-034644","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034644","line_url":"/filing/0001209191-18-034644#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45626.0,"shares_display":"45,626","price_per_share":90.07,"price_display":"90.07","price_state":"stated","total_value":4109533.82,"total_display":"4,109,533.82","total_whole":"4,109,534","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-06-01","scope":"insider"},{"id":6558381,"accession":"0001209191-18-033652","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-033652","line_url":"/filing/0001209191-18-033652","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49374.0,"shares_display":"49,374","price_per_share":90.4023111354154,"price_display":"90.40","price_state":"stated","total_value":4463523.71,"total_display":"4,463,523.71","total_whole":"4,463,524","shares_owned_after":9600.0,"shares_owned_after_display":"9,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-29","scope":"insider","n_lines":3},{"id":6421525,"accession":"0001209191-18-027582","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-027582","line_url":"/filing/0001209191-18-027582","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":83.03850153846153,"price_display":"83.04","price_state":"stated","total_value":1079500.52,"total_display":"1,079,500.52","total_whole":"1,079,501","shares_owned_after":2914.0,"shares_owned_after_display":"2,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-03","scope":"insider","n_lines":3},{"id":6076108,"accession":"0001209191-18-023581","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-023581","line_url":"/filing/0001209191-18-023581","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":77.71974230769231,"price_display":"77.72","price_state":"stated","total_value":1010356.65,"total_display":"1,010,356.65","total_whole":"1,010,357","shares_owned_after":2113.0,"shares_owned_after_display":"2,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider","n_lines":5},{"id":6518256,"accession":"0001209191-18-016471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-016471","line_url":"/filing/0001209191-18-016471","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":81.09370769230769,"price_display":"81.09","price_state":"stated","total_value":1054218.2,"total_display":"1,054,218.20","total_whole":"1,054,218","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider","n_lines":2},{"id":6452262,"accession":"0001209191-18-007529","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-007529","line_url":"/filing/0001209191-18-007529","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":78.75044615384616,"price_display":"78.75","price_state":"stated","total_value":1023755.8,"total_display":"1,023,755.80","total_whole":"1,023,756","shares_owned_after":4460.0,"shares_owned_after_display":"4,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider","n_lines":2},{"id":6630875,"accession":"0001209191-18-006004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-006004","line_url":"/filing/0001209191-18-006004","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23572.0,"shares_display":"23,572","price_per_share":81.09172195825556,"price_display":"81.09","price_state":"stated","total_value":1911494.07,"total_display":"1,911,494.07","total_whole":"1,911,494","shares_owned_after":2966.0,"shares_owned_after_display":"2,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-26","filed_date":"2018-01-30","scope":"insider","n_lines":3},{"id":6630845,"accession":"0001209191-18-005584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005584","line_url":"/filing/0001209191-18-005584#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":80.01,"price_display":"80.01","price_state":"stated","total_value":1600.2,"total_display":"1,600.20","total_whole":"1,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-26","scope":"insider"},{"id":6011532,"accession":"0001209191-18-005357","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-005357","line_url":"/filing/0001209191-18-005357#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13533.0,"shares_display":"13,533","price_per_share":80.01,"price_display":"80.01","price_state":"stated","total_value":1082775.33,"total_display":"1,082,775.33","total_whole":"1,082,775","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-25","scope":"insider"},{"id":6011526,"accession":"0001209191-18-005357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005357","line_url":"/filing/0001209191-18-005357#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32875.0,"shares_display":"32,875","price_per_share":80.01,"price_display":"80.01","price_state":"stated","total_value":2630328.75,"total_display":"2,630,328.75","total_whole":"2,630,329","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-25","scope":"insider"},{"id":6595991,"accession":"0001209191-18-003637","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-003637","line_url":"/filing/0001209191-18-003637#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22304.0,"shares_display":"22,304","price_per_share":73.02,"price_display":"73.02","price_state":"stated","total_value":1628638.08,"total_display":"1,628,638.08","total_whole":"1,628,638","shares_owned_after":17511.0,"shares_owned_after_display":"17,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-16","scope":"insider"},{"id":6595988,"accession":"0001209191-18-003637","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-003637","line_url":"/filing/0001209191-18-003637#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001578200","owner_name":"Schenkein David P","owner_display_name":"Schenkein David P","owner_url":"/insider/0001578200","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13185.0,"shares_display":"13,185","price_per_share":71.77,"price_display":"71.77","price_state":"stated","total_value":946287.45,"total_display":"946,287.45","total_whole":"946,287","shares_owned_after":39815.0,"shares_owned_after_display":"39,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-16","scope":"insider"}],"collapsed":true,"next_cursor":"2018-01-16|6595988","ledger_fault":false,"count":{"value":112,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":110,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":112},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Director","n_filings":5,"first_seen":"2020-11-06","last_seen":"2024-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director, Officer (Chief Executive Officer)","n_filings":56,"first_seen":"2014-07-02","last_seen":"2024-02-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Director","n_filings":3,"first_seen":"2014-12-22","last_seen":"2017-09-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578200","retrieved_at":"2026-08-23T07:33:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}